UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
|
☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2018
or
|
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number: 001-33301
ACCURAY INCORPORATED
(Exact Name of Registrant as Specified in Its Charter)
Delaware |
|
20-8370041 |
(State or Other Jurisdiction of Incorporation or Organization) |
|
(IRS Employer Identification Number) |
1310 Chesapeake Terrace
Sunnyvale, California 94089
(Address of Principal Executive Offices Including Zip Code)
(408) 716-4600
(Registrant’s Telephone Number, Including Area Code)
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer |
☐ |
|
Accelerated filer |
☒ |
Non-accelerated filer |
☐ |
|
Smaller reporting company |
☐ |
|
|
|
Emerging growth company |
☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No
As of October 29, 2018, there were 86,660,010 shares of the Registrant’s Common Stock, par value $0.001 per share, outstanding.
|
|
Page No. |
|
|
|
PART I. |
Financial Information |
|
|
|
|
Item 1. |
3 |
|
|
|
|
|
Unaudited Condensed Consolidated Balance Sheets as of September 30, 2018 and June 30, 2018 |
3 |
|
|
|
|
4 |
|
|
|
|
|
5 |
|
|
|
|
|
Notes to Unaudited Condensed Consolidated Financial Statements |
6 |
|
|
|
Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
22 |
|
|
|
Item 3. |
32 |
|
|
|
|
Item 4. |
33 |
|
|
|
|
PART II. |
Other Information |
|
|
|
|
Item 1. |
34 |
|
|
|
|
Item 1A. |
34 |
|
|
|
|
Item 2. |
60 |
|
|
|
|
Item 3. |
60 |
|
|
|
|
Item 4. |
60 |
|
|
|
|
Item 5. |
60 |
|
|
|
|
Item 6. |
61 |
|
|
|
|
|
62 |
We own or have rights to various trademarks and tradenames used in our business in the United States or other countries, including the following: Accuray®, Accuray Logo®, CyberKnife®, Hi‑Art®, RayStation®, RoboCouch®, Synchrony®, TomoTherapy®, Xsight®, Accuray Precision®, AutoSegmentation™, CTrue™, H™ Series, iDMS® InCise™, Iris™, M6™ Series, OIS Connect™, PlanTouch®, PreciseART®, PreciseRTX®, Treatment Planning System™, QuickPlan®, TomoDirect™, TomoEdge™, TomoH®, TomoHD®, TomoHDA™, TomoHelical™, Tomo Quality Assurance™, Radixact®, Onrad ™, StatRT™, and VoLO™. ImagingRing® is a registered trademark belonging to medPhoton GmbH. RayStation® is a registered trademark belonging to RaySearch Laboratories, AB.
2
Accuray Incorporated
Unaudited Condensed Consolidated Balance Sheets
(in thousands, except share amounts and par value)
|
|
September 30, 2018 |
|
|
June 30, 2018 |
|
||
ASSETS |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
68,545 |
|
|
$ |
83,083 |
|
Restricted cash |
|
|
1,969 |
|
|
|
9,830 |
|
Accounts receivable, net of allowance for doubtful accounts of $661 and $251 as of September 30, 2018 and June 30, 2018, respectively |
|
|
66,420 |
|
|
|
65,994 |
|
Inventories |
|
|
117,684 |
|
|
|
108,540 |
|
Prepaid expenses and other current assets |
|
|
17,075 |
|
|
|
15,569 |
|
Deferred cost of revenue |
|
|
220 |
|
|
|
1,141 |
|
Total current assets |
|
|
271,913 |
|
|
|
284,157 |
|
Property and equipment, net |
|
|
23,126 |
|
|
|
23,698 |
|
Goodwill |
|
|
57,767 |
|
|
|
57,855 |
|
Intangible assets, net |
|
|
785 |
|
|
|
821 |
|
Restricted cash |
|
|
791 |
|
|
|
620 |
|
Other assets |
|
|
14,749 |
|
|
|
11,576 |
|
Total assets |
|
$ |
369,131 |
|
|
$ |
378,727 |
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
25,921 |
|
|
$ |
19,694 |
|
Accrued compensation |
|
|
21,857 |
|
|
|
28,992 |
|
Other accrued liabilities |
|
|
21,240 |
|
|
|
22,448 |
|
Customer advances |
|
|
19,181 |
|
|
|
22,896 |
|
Deferred revenue |
|
|
72,278 |
|
|
|
75,404 |
|
Total current liabilities |
|
|
160,477 |
|
|
|
169,434 |
|
Long-term liabilities: |
|
|
|
|
|
|
|
|
Long-term other liabilities |
|
|
9,890 |
|
|
|
8,608 |
|
Deferred revenue |
|
|
22,732 |
|
|
|
20,976 |
|
Long-term debt |
|
|
128,926 |
|
|
|
131,077 |
|
Total liabilities |
|
|
322,025 |
|
|
|
330,095 |
|
Commitments and contingencies (Note 9) |
|
|
|
|
|
|
|
|
Stockholders' equity: |
|
|
|
|
|
|
|
|
Common stock, $0.001 par value; authorized: 200,000,000 shares as of September 30, 2018 and June 30, 2018, respectively; issued and outstanding: 86,500,260 and 86,129,256 shares at September 30, 2018 and June 30, 2018, respectively |
|
|
86 |
|
|
|
86 |
|
Additional paid-in-capital |
|
|
524,699 |
|
|
|
521,738 |
|
Accumulated other comprehensive income |
|
|
698 |
|
|
|
1,093 |
|
Accumulated deficit |
|
|
(478,377 |
) |
|
|
(474,285 |
) |
Total stockholders' equity |
|
|
47,106 |
|
|
|
48,632 |
|
Total liabilities and stockholders' equity |
|
$ |
369,131 |
|
|
$ |
378,727 |
|
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
3
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss
(in thousands, except per share amounts)
|
|
Three Months Ended September 30, |
|
|||||
|
|
2018 |
|
|
2017 |
|
||
Net revenue: |
|
|
|
|
|
|
|
|
Products |
|
$ |
41,517 |
|
|
$ |
38,916 |
|
Services |
|
|
54,312 |
|
|
|
52,034 |
|
Total net revenue |
|
|
95,829 |
|
|
|
90,950 |
|
Cost of revenue: |
|
|
|
|
|
|
|
|
Cost of products |
|
|
24,524 |
|
|
|
22,102 |
|
Cost of services |
|
|
33,426 |
|
|
|
30,742 |
|
Total cost of revenue |
|
|
57,950 |
|
|
|
52,844 |
|
Gross profit |
|
|
37,879 |
|
|
|
38,106 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
Research and development |
|
|
13,889 |
|
|
|
14,093 |
|
Selling and marketing |
|
|
13,036 |
|
|
|
14,757 |
|
General and administrative |
|
|
15,642 |
|
|
|
11,308 |
|
Total operating expenses |
|
|
42,567 |
|
|
|
40,158 |
|
Loss from operations |
|
|
(4,688 |
) |
|
|
(2,052 |
) |
Other expense, net |
|
|
(3,983 |
) |
|
|
(6,571 |
) |
Loss before provision for income taxes |
|
|
(8,671 |
) |
|
|
(8,623 |
) |
Provision for income taxes |
|
|
535 |
|
|
|
759 |
|
Net loss |
|
$ |
(9,206 |
) |
|
$ |
(9,382 |
) |
Net loss per share - basic and diluted |
|
$ |
(0.11 |
) |
|
$ |
(0.11 |
) |
Weighted average common shares used in computing net loss per share: |
|
|
|
|
|
|
|
|
Basic and diluted |
|
|
86,479 |
|
|
|
83,747 |
|
Net loss |
|
$ |
(9,206 |
) |
|
$ |
(9,382 |
) |
Foreign currency translation adjustment |
|
|
(395 |
) |
|
|
346 |
|
Unrealized gain (loss) on investments, net of tax |
|
|
— |
|
|
|
22 |
|
Comprehensive loss |
|
$ |
(9,601 |
) |
|
$ |
(9,014 |
) |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
4
Unaudited Condensed Consolidated Statements of Cash Flows
(in thousands)
|
|
Three Months Ended September 30, |
|
|||||
|
|
2018 |
|
|
2017 |
|
||
Cash flows from operating activities |
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(9,206 |
) |
|
$ |
(9,382 |
) |
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
2,129 |
|
|
|
2,514 |
|
Share-based compensation |
|
|
3,212 |
|
|
|
2,432 |
|
Amortization of debt issuance costs |
|
|
380 |
|
|
|
448 |
|
Accretion of interest on debt |
|
|
811 |
|
|
|
862 |
|
Provision for bad debt |
|
|
3,737 |
|
|
|
8 |
|
Provision for write-down of inventories |
|
|
713 |
|
|
|
354 |
|
Loss on disposal of property and equipment |
|
|
19 |
|
|
|
11 |
|
Loss on extinguishment of debt |
|
|
— |
|
|
|
3,192 |
|
Changes in assets and liabilities: |
|
|
|
|
|
|
|
|
Accounts receivable |
|
|
(1,377 |
) |
|
|
1,932 |
|
Inventories |
|
|
(10,150 |
) |
|
|
(8,792 |
) |
Prepaid expenses and other assets |
|
|
(1,096 |
) |
|
|
2,506 |
|
Deferred cost of revenue |
|
|
459 |
|
|
|
991 |
|
Accounts payable |
|
|
6,256 |
|
|
|
4,791 |
|
Accrued liabilities |
|
|
(8,564 |
) |
|
|
(11,653 |
) |
Customer advances |
|
|
(3,723 |
) |
|
|
2,374 |
|
Deferred revenues |
|
|
(1,423 |
) |
|
|
(5,615 |
) |
Net cash used in operating activities |
|
|
(17,823 |
) |
|
|
(13,027 |
) |
Cash flows from investing activities |
|
|
|
|
|
|
|
|
Purchases of property and equipment, net |
|
|
(1,602 |
) |
|
|
(929 |
) |
Net cash used in investing activities |
|
|
(1,602 |
) |
|
|
(929 |
) |
Cash flows from financing activities |
|
|
|
|
|
|
|
|
Proceeds from employee stock plans |
|
|
837 |
|
|
|
900 |
|
Taxes paid related to net share settlement of equity awards |
|
|
— |
|
|
|
(19 |
) |
Proceeds from debt, net of costs |
|
|
— |
|
|
|
27,282 |
|
Payments made to note and loan holders |
|
|
— |
|
|
|
(29,581 |
) |
Borrowings (repayments) under Revolving Credit Facility, net |
|
|
(3,263 |
) |
|
|
251 |
|
Net cash used in financing activities |
|
|
(2,426 |
) |
|
|
(1,167 |
) |
Effect of exchange rate changes on cash, cash equivalents and restricted cash |
|
|
(377 |
) |
|
|
684 |
|
Net decrease in cash, cash equivalents and restricted cash |
|
|
(22,228 |
) |
|
|
(14,439 |
) |
Cash, cash equivalents and restricted cash at beginning of period |
|
|
93,533 |
|
|
|
85,235 |
|
Cash, cash equivalents and restricted cash at end of period |
|
$ |
71,305 |
|
|
$ |
70,796 |
|
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
5
Notes to Unaudited Condensed Consolidated Financial Statements
Note 1. The Company and its Significant Accounting Policies
The Company
Accuray Incorporated (together with its subsidiaries, the “Company” or “Accuray”) designs, develops and sells advanced radiosurgery and radiation therapy systems for the treatment of tumors throughout the body. The Company is incorporated in Delaware and has its principal place of business in Sunnyvale, California. The Company has primary offices in the United States, Switzerland, China, Hong Kong and Japan and conducts its business worldwide.
Basis of Presentation
The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant inter-company transactions and balances have been eliminated in consolidation.
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”), pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and note disclosures have been condensed or omitted pursuant to such rules and regulations. The unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for a fair presentation of the periods presented. The results for the three months ended September 30, 2018 are not necessarily indicative of the results to be expected for the fiscal year ending June 30, 2019, or for any other future interim period or fiscal year.
These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and accompanying notes for the fiscal year ended June 30, 2018 included in the Company’s Annual Report on Form 10-K filed with the SEC on August 24, 2018.
Significant Accounting Policies
The Company adopted the Accounting Standard Codification (“ASC”) 606, Revenue from Contracts with Customers as of July 1, 2018, using the modified retrospective method. See Note 2. Recent Accounting Pronouncements and Note 3. Revenue, to our unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for additional details. Except for the changes in the revenue recognition policy, there have been no other material changes to the Company’s accounting policies from the information provided in Note 1. The Company and its Significant Accounting Policies to the audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2018.
Revenue Recognition
The Company’s revenue is primarily derived from sales of CyberKnife and TomoTherapy Systems and services, which include post-contract customer support (“PCS”), installation services, training and other professional services.
The Company has a contract with a customer when there is approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable.
The Company’s customary practice is to have a signed contract with customers. The Company's revenues are measured based on consideration specified in the contract with each customer, net of any sales incentives and amounts collected on behalf of third parties such as sales taxes, excise taxes, and VAT.
The majority of the Company's revenue arrangements consists of multiple performance obligations, which can include system, upgrades, installation, training, services, construction, and consumables. For bundled arrangements, the Company accounts for individual products and services separately if a product or service is separately identifiable from other items in the bundled package and if a customer can benefit from it on its own or with other resources that are readily available to the customer.
6
The Company’s products are generally not sold with a right of return, and the Company’s contracts generally provide a fixed transaction price. However, the Company from time to time offers variable consideration such as volume discounts. The Company also offers extended payment terms beyond one year, trade-in allowance for old systems, and commissions or other forms of payment to customers.
The stand-alone selling price (“SSP”) of performance obligations is determined based on observable prices at which the Company separately sells the products and services. If the SSP is not directly observable, then the Company will estimate the SSP considering market conditions, entity-specific factors, and information about the customer or class of customer that is reasonably available. The SSP is generally assessed as a percentage of the list price. The contract consideration allocation is based on the SSP at contract inception. The consideration (net of any discounts) is allocated among separate products and services in a bundle based on their individual SSP. For contract modifications that add additional goods or services or changes pricing, the SSP is used for allocation to the remaining performance obligations.
The Company recognizes revenue for certain performance obligations at the point in time when control is transferred, such as delivery of products. The Company recognizes revenue for certain other performance obligations over a period of time as control of the goods or services is transferred, such as PCS and construction contracts.
The Company recognizes an asset for the incremental costs of obtaining a contract with a customer if the Company expects the benefit of those costs to be longer than one year. The Company capitalizes incremental contract acquisition costs, and amortizes such costs over the period which the Company expects to benefit, as estimated by management, which may extend beyond the initial contract term. Most of the Company’s contract costs are associated with its internal sales force compensation program and a portion of its employee bonus program. The Company amortizes capitalized bonuses and a portion of sales commissions over a period of five years commencing upon the initial transfer of control of the system to the customer. The pattern of amortization is commensurate with the pattern of transfer of control of the performance obligations to the customer. The Company elected to use the practical expedient in ASC 340-40-25-4 and expense as incurred commissions related to service renewals and upgrades because the contract term is less than a year.
Note 2. Recent Accounting Pronouncements
Accounting Pronouncement Recently Adopted
In June 2018, the Financial Accounting Standard Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2018-7, Compensation – Stock Compensation (Topic 718) )— Improvements to Nonemployee Share-Based Payment Accounting. This guidance supersedes ASC 505-50 and expands the scope of ASC 718 to include all share-based payment arrangements related to the acquisition of goods and services from both nonemployees and employees. The amendments should be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. The guidance permits early adoption and was adopted by the Company in the first quarter of fiscal year 2019. The adoption of this ASU did not have any impact on the Company’s consolidated financial statements and related disclosures.
In May 2017, the FASB issued ASU No. 2017-09, Compensation—Stock Compensation (Topic 718)—Scope of Modification Accounting. This guidance redefines which changes to the terms and conditions of a share-based payment award require an entity to apply modification accounting for a share-based payment. Modification accounting will not be applied if the following are the same immediately before and after the change: fair value, vesting conditions, and classification. The Company adopted ASU No. 2017-09 as required in the first quarter of fiscal 2019 on a prospective basis. The adoption of this ASU did not have any impact on the Company’s consolidated financial statements and related disclosures.
In March 2017, the FASB issued ASU No. 2017-07, Compensation—Retirement Benefits (Topic 715)—Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost. This guidance revises the presentation of employer-sponsored defined benefit pension and other postretirement plans for the net periodic benefit cost in the statement of operations and requires that the service cost component of net periodic benefit be presented in the same income statement line items as other employee compensation costs for services rendered during the period. The other components of the net benefit costs are required to be presented in the statement of operations separately from the service cost component and outside the subtotal of income from operations. This guidance allows only the service cost component of net periodic benefit costs to be eligible for capitalization. In addition, changes to the presentation of benefit costs were required to be adopted retrospectively, while changes to the capitalization of service costs into inventories were required to be adopted prospectively. The standard permits, as a practical expedient, use of the amounts disclosed in the pension plans footnote for the prior comparative periods as the estimation basis for applying the retrospective presentation requirement. The Company adopted ASU No. 2017-07 as required in the first quarter of fiscal 2019, and the adoption of this ASU did not have a material impact on the Company’s consolidated financial statements and related disclosures.
7
In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments, which clarifies the presentation and classification of certain cash receipts and cash payments in the statement of cash flows. The amendments in the update provide guidance on eight specific cash flow issues. The amendments to the guidance should be applied using a retrospective transition method for each period presented and, if it is impracticable to apply all of the amendments retrospectively for some of the issues, the amendments for those issues would be applied prospectively as of the earliest date practicable. The Company adopted ASU No. 2016-15 as required in the first quarter of fiscal 2019. The adoption of this ASU did not have any impact on the Company’s consolidated financial statements and related disclosures.
In January 2016, the FASB issued ASU No. 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities (ASU 2016-01). This guidance changes accounting for equity investments, financial liabilities under the fair value option and the presentation and disclosure requirements for financial instruments. In addition, it clarified guidance related to the valuation allowance assessment when recognizing deferred tax assets resulting from unrealized losses on available-for-sale debt securities. The Company adopted this ASU No. 2016-01 as required in the first quarter of fiscal 2019 on a required modified retrospective approach. The adoption of this ASU did not have any impact on the Company’s consolidated financial statements and related disclosures.
In January 2017, the FASB issued ASU No. 2017-04, Intangibles-Goodwill and Other Topics (Topic 350)-Simplifying the Test for Goodwill Impairment. This guidance simplifies the measurement of goodwill by eliminating the Step 2 impairment test. The new guidance requires companies to perform the goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. This guidance will be effective for the Company beginning in its first quarter of fiscal 2021. The amendment is required to be adopted prospectively. Early adoption is permitted for goodwill impairment tests performed on testing dates after January 1, 2017. The Company early adopted this guidance in the first quarter of fiscal 2019 and adoption of this ASU did not have any impact on its consolidated financial statements and related disclosures.
In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), to supersede nearly all existing revenue recognition guidance under GAAP. The core principle of ASU 2014-09 is to recognize revenue when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. ASU 2014-09 defines a five-step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing GAAP, including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. ASU 2014-09 is required to be adopted, using either of two methods: (i) retrospective to each prior reporting period presented with the option to elect certain practical expedients as defined within ASU 2014-09; or (ii) retrospective with the cumulative effect of initially applying ASU 2014-09 recognized at the date of initial application and providing certain additional disclosures. The Company adopted the new revenue standards as of July 1, 2018, using the modified retrospective transition method applied to those contracts which were not completed as of that date.
The Company completed its assessment of the impact this guidance has on its consolidated financial statements and related disclosures. Based on that assessment, the Company concluded the significant impact areas were the capitalization and amortization of incremental costs of obtaining a contract, primarily related to certain bonuses and sales commissions, change in SSP and the removal of software revenue recognition rules along with the elimination of revenue deferral for cash basis customers. Under the new standards, the Company capitalizes incremental contract acquisition costs, such as certain bonuses and sales commissions, and amortizes such costs over the period which the Company benefits, as estimated by management, which may extend beyond the initial contract term. The Company amortizes capitalized bonuses and sales commissions over a period of five years commencing upon the initial transfer of control of the system to the customer. The pattern of amortization is commensurate with the pattern of transfer of control of the performance obligations to the customer. The Company elected to use the practical expedient in ASC 340-40-25-4 and expense commissions related to service renewals and upgrades with a renewal contract term of one year or less as incurred. The Company recorded a net reduction to opening accumulated deficit of $5.1 million, net of tax, as of July 1, 2018 due to the cumulative impact of adopting ASC 606, with the impact primarily related to the deferral of incremental costs to obtain contracts.
Under ASC 606, product revenue for direct sales will be accelerated to reflect transfer of control upon delivery while an element of installation will be deferred until performed. Prior to the adoption of ASC 606, the Company deferred revenue until installation had occurred. The revenue recognition method for indirect sales and service revenues is unchanged under the new guidance.
Refer to Note 3, Revenue, to the Unaudited Condensed Consolidated Financial Statement on this Quarterly report for the detailed impact of adopting ASC 606.
8
Accounting Pronouncements Not Yet Effective
In February 2018, the FASB issued ASU No. 2018-2, Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income, that allows companies to reclassify from Accumulated Other Comprehensive Income to Retained Earnings stranded tax effects resulting from the enactment of the Tax Cuts and Jobs Act (the "Tax Act"). The guidance will be effective for the Company in its first quarter of fiscal 2020. Early adoption is permitted. The guidance should be applied either in the period of adoption or retrospectively to each period in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Cuts and Jobs Act is recognized. The Company has not yet selected a transition method, has not yet determined whether it will elect early adoption and is currently evaluating the impact of the adoption of this standard on its consolidated financial statements and related disclosures.
In August 2017, the FASB issued ASU No. 2017-12, Derivatives and Hedging. This guidance simplifies the application and administration of hedge accounting. The guidance amends the presentation and disclosure requirements and changes how companies assess effectiveness. The guidance is intended to more closely align hedge accounting with companies' risk management strategies, simplify the application of hedge accounting, and increase transparency as to the scope and results of hedging programs. The guidance will be effective for the Company in its first quarter of fiscal 2020. Early adoption is permitted. The guidance is required to be adopted on a prospective basis. The Company will not early adopt and does not believe the adoption of this standard will have a material impact on its consolidated financial statements and related disclosures.
In June 2016, the FASB issued ASU No. 2016-13 Measurement of Credit Losses on Financial Instruments (ASU 2016-13). ASU 2016-13 requires measurement and recognition of expected credit losses for financial assets held. This guidance will be effective for the Company in the first quarter of fiscal 2021 and must be adopted using a modified retrospective approach, with certain exceptions. Early adoption is permitted beginning in the first quarter of fiscal 2020. The Company has not yet decided whether it will early adopt and is currently evaluating the impact of the adoption of this standard on its consolidated financial statements and related disclosures.
In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842). Under the new guidance, a lessee will be required to recognize assets and liabilities for all leases with lease terms of more than 12 months. Consistent with current GAAP, the recognition, measurement, and presentation of expenses and cash flows arising from a lease by a lessee primarily will depend on its classification as a finance or operating lease. This guidance will be effective for the Company in the first quarter of fiscal 2020 and early adoption is permitted. In July 2018, the FASB issued ASU No. 2018-11, Targeted Improvements, which provides another transition method in addition to the existing modified retrospective transition approach. Accordingly, the new method allows entities to initially apply the new leases standard at the adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. The Company intends to adopt the allowed transition method allowed under ASU 2018-11, but will not elect early adoption, and is currently evaluating the impact of the adoption of this standard on its consolidated financial statements and related disclosures.
Note 3. Revenue
On July 1, 2018 the Company adopted ASC 606 electing the modified retrospective method for contracts that were still open as of July 1, 2018. Results for reporting periods after July 1, 2018 are presented under ASC 606, while prior period amounts are not adjusted and continue to be reported in accordance with legacy accounting guidance under ASC 605.
The beginning net cumulative-effect adjustment to retained earnings for the adoption of ASC 606 is as follows:
|
|
Balance at |
|
|
Adjustment Due to |
|
|
Balance at |
|
|||
(Dollars in thousands) |
|
June 30, 2018 |
|
|
ASC 606 |
|
|
July 1, 2018 |
|
|||
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
Account receivable, net |
|
$ |
65,994 |
|
|
$ |
257 |
|
|
$ |
66,251 |
|
Deferred cost of revenue - current |
|
|
1,141 |
|
|
|
(464 |
) |
|
|
677 |
|
Prepaid expenses and other current assets |
|
|
15,569 |
|
|
|
670 |
|
|
|
16,239 |
|
Other assets |
|
|
11,576 |
|
|
|
5,840 |
|
|
|
17,416 |
|
Liabilities and Stockholders' Equity: |
|
|
|
|
|
|
|
|
|
|
|
|
Other accrued liabilities |
|
|
22,448 |
|
|
|
611 |
|
|
|
23,059 |
|
Deferred revenue - current |
|
|
75,404 |
|
|
|
111 |
|
|
|
75,515 |
|
Long-term other liabilities |
|
|
8,608 |
|
|
|
467 |
|
|
|
9,075 |
|
Accumulated deficit |
|
|
(474,285 |
) |
|
|
5,114 |
|
|
|
(469,171 |
) |
9
Select unaudited condensed consolidated balance sheets line items, which reflect the adoption of ASC 606 are as follows:
|
|
September 30, 2018 |
|
|||||||||
(Dollars in thousands) |
|
Balances Without Adoption |
|
|
Adjustments |
|
|
As Reported |
|
|||
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
Account receivable, net |
|
$ |
61,798 |
|
|
$ |
4,622 |
|
|
$ |
66,420 |
|
Deferred cost of revenue - current |
|
|
11,300 |
|
|
|
(11,080 |
) |
|
|
220 |
|
Prepaid expenses and other current assets |
|
|
16,118 |
|
|
|
957 |
|
|
|
17,075 |
|
Other assets |
|
|
8,711 |
|
|
|
6,038 |
|
|
|
14,749 |
|
Liabilities and Stockholders' Equity: |
|
|
|
|
|
|
|
|
|
|
|
|
Other accrued liabilities |
|
|
20,606 |
|
|
|
634 |
|
|
|
21,240 |
|
Deferred revenue - current |
|
|
86,592 |
|
|
|
(14,314 |
) |
|
|
72,278 |
|
Long-term other liabilities |
|
|
9,186 |
|
|
|
704 |
|
|
|
9,890 |
|
Accumulated deficit |
|
|
(491,890 |
) |
|
|
13,513 |
|
|
|
(478,377 |
) |
Select unaudited condensed consolidated statements of operations and comprehensive loss line items for the three months ended September 30, 2018, which reflect the adoption of ASC 606 are as follows:
|
|
Three Months Ended September 30, 2018 |
|
|||||||||
(Dollars in thousands) |
|
Balances Without Adoption |
|
|
Adjustments |
|
|
As Reported |
|
|||
Net revenue |
|
$ |
77,114 |
|
|
$ |
18,715 |
|
|
$ |
95,829 |
|
Cost of goods sold |
|
|
47,356 |
|
|
|
10,594 |
|
|
|
57,950 |
|
Other expense, net |
|
|
4,071 |
|
|
|
(88 |
) |
|
|
3,983 |
|
Research and development |
|
|
13,921 |
|
|
|
(32 |
) |
|
|
13,889 |
|
Selling and marketing |
|
|
13,226 |
|
|
|
(190 |
) |
|
|
13,036 |
|
General and administrative |
|
|
15,685 |
|
|
|
(43 |
) |
|
|
15,642 |
|
Provision for income taxes |
|
|
460 |
|
|
|
75 |
|
|
|
535 |
|
Net income (loss) |
|
|
(17,605 |
) |
|
|
8,399 |
|
|
|
(9,206 |
) |
Net income (loss) per share - Basic and Diluted |
|
$ |
(0.21 |
) |
|
$ |
0.10 |
|
|
$ |
(0.11 |
) |
The adoption of ASC 606 had no impact to net cash from or used in operating, investing or financing activities in the Company's unaudited condensed consolidated statements of cash flows.
10
The timing of revenue recognition, billings, and cash collections results in trade, unbilled receivables, and deferred revenues on the unaudited condensed consolidated statement of balance sheets. The Company may offer longer or extended payments of more than one year for qualified customers in some circumstances. At times, revenue recognition occurs before the billing, resulting in an unbilled receivable, which represents a contract asset. The contract asset is a component of accounts receivable and other assets for the current and non-current portions, respectively.
When the Company receives advances or deposits from customers before revenue is recognized, this results in deferred revenues, which represents a contract liability. It can take up to two and half years from the time of order to revenue recognition due to the Company’s long sales cycle.
Changes in the contract assets and contract liabilities are as follows:
|
|
July 1, 2018 |
|
|
September 30, 2018 |
|
|
Change |
|
|||||||
(Dollars in thousands) |
|
Amount |
|
|
Amount |
|
|
$ |
|
|
% |
|
||||
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unbilled accounts receivable - current (1) |
|
$ |
3,218 |
|
|
$ |
11,105 |
|
|
|
7,887 |
|
|
|
71 |
|
Long Term Accounts Receivable (2) |
|
|
6,833 |
|
|
|
4,189 |
|
|
|
(2,644 |
) |
|
|
(63 |
) |
Interest receivable - non-current (2) |
|
|
611 |
|
|
|
701 |
|
|
|
90 |
|
|
|
13 |
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Customer advances |
|
|
22,896 |
|
|
|
19,181 |
|
|
|
(3,715 |
) |
|
|
(19 |
) |
Deferred revenue - current |
|
|
75,515 |
|
|
|
72,278 |
|
|
|
(3,237 |
) |
|
|
(4 |
) |
Deferred revenue - non-current |
|
|
20,976 |
|
|
|
22,732 |
|
|
|
1,756 |
|
|
|
8 |
|
|
(1) |
Included in accounts receivable on consolidated balance sheets |
|
(2) |
Included in other assets on consolidated balance sheets |
Changes in deferred revenue from contracts with customers are as follows:
|
|
Three Months Ended |
|
|
(Dollars in thousands) |
|
September 30, 2018 |
|
|
Balance at beginning of period |
|
$ |
96,491 |
|
New billings |
|
|
94,348 |
|
Recoginition of deferred revenue |
|
|
(95,829 |
) |
Balance at end of period |
|
$ |
95,010 |
|
Remaining Performance Obligations
Remaining performance obligations represent deferred revenue from open contracts for which performance has already started and the transaction price from signed contracts for which performance has not yet started. Service contracts in general are considered month-to-month contracts, and therefore, the Company has elected the practical expedients available in the guidance related to ASC 606, to not disclose the value of unsatisfied performance obligations for contracts with an original expected duration of one year or less.
As of September 30, 2018, total remaining performance obligations amounted to $731.0 million. Of this total amount, $66.5 million related to long-term warranty and service, which is expected to be recognized over the remaining warranty period for systems that have been delivered. For system that have been delivered but not yet installed, management estimates the timing of installation since warranty starts upon installation.
The following table represents the Company's remaining performance obligations related to long-term warranty and service as of September 30, 2018 and the estimated revenue expected to be recognized:
|
|
Fiscal years of revenue recognition |
|
|||||||||||||
(Dollars in thousands) |
|
2019 |
|
|
2020 |
|
|
2021 |
|
|
Thereafter |
|
||||
Long-term warranty and service |
|
$ |
22,411 |
|
|
$ |
21,862 |
|
|
$ |
12,939 |
|
|
$ |
9,255 |
|
11
For the remaining $664.5 million of performance obligations, the Company estimates 30% to 40% will be recognized in the next 12 months, and the remaining 60% to 70% will be recognized in the 30 months thereafter. The Company’s historical experience indicates that some of its customers will cancel or renegotiate contracts as economic conditions change or when product offerings change during the long sales cycle. As such, about 15% to 20% of the Company’s contracts may never result in revenue due to cancellation.
The time bands reflect management’s best estimate of when the Company will transfer control to the customer and may change based on timing of shipment, readiness of customers’ facilities for installation, installation requirements, and availability of products.
Capitalized Contract Costs
The Company capitalizes and amortizes the incremental costs of obtaining a contract, primarily related to certain bonuses and sales commissions. The capitalized bonuses and sales commissions are amortized over a period of five years commencing upon the initial transfer of control of the system to the customer. The pattern of amortization is commensurate with the pattern of transfer of control of the performance obligations to the customer.
The opening balance of capitalized costs to obtain a contract was $5.9 million as of July 1, 2018. As of September 30, 2018, the balance of capitalized costs to obtain a contract was $6.2 million. The Company has classified the capitalized costs to obtain a contract as a component of prepaid expenses and other current assets and other assets with respect to the current and non-current portions of capitalized costs, respectively, on the consolidated balance sheets. The Company did not incur any impairment losses during any of the periods presented. During the three months ended September 30, 2018, the Company recognized $0.9 million in expense related to the amortization of the capitalized contract costs.
Note 4. Supplemental Financial Information
Balance Sheet Components
Financing receivables
A financing receivable is a contractual right to receive money, on demand or on fixed or determinable dates, that is recognized as an asset on the Company’s balance sheet. The Company’s financing receivables, consisting of its accounts receivable with contractual maturities of more than one year and sales-type leases, totaled $4.2 million and $6.9 million at September 30, 2018 and June 30, 2018, respectively, and are included in other assets in the unaudited condensed consolidated balance sheets. The Company evaluates the credit quality of an obligor at lease or contract inception and monitors credit quality over the term of the underlying transactions. The Company performs a credit analysis for all new customers and reviews payment history, current order backlog, financial performance of the customers and other variables that augment or mitigate the inherent credit risk of a transaction. Such variables include the underlying value and liquidity of the collateral, the essential use of the equipment, the term of the lease and the inclusion of credit enhancements, such as guarantees, letters of credit or security deposits. The Company classifies accounts as high risk when it considers the financing receivable to be impaired or when management believes there is a significant near-term risk of non-payment. As of September 30, 2018, the sales-type lease portion of the financing receivables was rated at a moderate risk. The Company performed an assessment of the allowance for credit losses related to its financing receivables as of September 30, 2018 and June 30, 2018. Based upon such assessment, the Company recorded $3.3 million and zero adjustment to the allowance for credit losses related to such financing receivables as of September 30, 2018 and as of June 30, 2018, respectively.
A summary of the Company’s financing receivables is presented as follows (in thousands):
September 30, 2018 |
|
Lease Receivables |
|
|
Financed Service Contracts and Other |
|
|
Total |
|
|||
Gross |
|
$ |
1,472 |
|
|
$ |
13,841 |
|
|
$ |
15,313 |
|
Unearned income |
|
|
(113 |
) |
|
|
(1,036 |
) |
|
|
(1,149 |
) |
Allowance for credit loss |
|
|
— |
|
|
|
(3,327 |
) |
|
|
(3,327 |
) |
Total, net |
|
$ |
1,359 |
|
|
$ |
9,478 |
|
|
$ |
10,837 |
|
Reported as: |
|
|
|
|
|
|
|
|
|
|
|
|
Current |
|
$ |
444 |
|
|
$ |
6,204 |
|
|
|
6,648 |
|
Non-current |
|
|
915 |
|
|
|
3,274 |
|
|
|
4,189 |
|
Total, net |
|
$ |
1,359 |
|
|
$ |
9,478 |
|
|
$ |
10,837 |
|
12
June 30, 2018 |
|
Lease Receivables |
|
|
Financed Service Contracts and Other |
|
|
Total |
|
|||
Gross |
|
$ |
1,588 |
|
|
$ |
8,009 |
|
|
$ |
9,597 |
|
Unearned income |
|
|
(137 |
) |
|
|
— |
|
|
$ |
(137 |
) |
Allowance for credit loss |
|
|
— |
|
|
|
— |
|
|
$ |
— |
|
Total, net |
|
|
1,451 |
|
|
|
8,009 |
|
|
|
9,460 |
|
Reported as: |
|
|
|
|
|
|
|
|
|
|
|
|
Current |
|
$ |
432 |
|
|
$ |
2,139 |
|
|
$ |
2,571 |
|
Non-current |
|
|
1,019 |
|
|
|
5,870 |
|
|
|
6,889 |
|
Total, net |
|
$ |
1,451 |
|
|
$ |
8,009 |
|
|
$ |
9,460 |
|
Actual cash collections may differ from the contracted maturities due to early customer buyouts, refinancing, or defaults. Future minimum lease payments to be received as of September 30, 2018 are presented as follows (in thousands):
Year Ending June 30, |
|
Amount |
|
|
2019 (remaining 9 months) |
|
$ |
387 |
|
2020 |
|
|
465 |
|
2021 |
|
|
465 |
|
2022 |
|
|
155 |
|
Total |
|
$ |
1,472 |
|
Inventories
Inventories consisted of the following (in thousands):
|
|
September 30, 2018 |
|
|
June 30, 2018 |
|
||
Raw materials |
|
$ |
44,417 |
|
|
$ |
37,144 |
|
Work-in-process |
|
|
17,189 |
|
|
|
17,703 |
|
Finished goods |
|
|
56,078 |
|
|
|
53,693 |
|
Inventories |
|
$ |
117,684 |
|
|
$ |
108,540 |
|
Property and equipment, net
Property and equipment, net consisted of the following (in thousands):
|
|
September 30, 2018 |
|
|
June 30, 2018 |
|
||
Furniture and fixtures |
|
$ |
2,910 |
|
|
$ |
2,927 |
|
Computer and office equipment |
|
|
10,789 |
|
|
|
11,315 |
|
Software |
|
|
10,840 |
|
|
|
11,307 |
|
Leasehold improvements |
|
|
25,742 |
|
|
|
25,423 |
|
Machinery and equipment |
|
|
42,736 |
|
|
|
47,065 |
|
Construction in progress |
|
|
6,433 |
|
|
|
5,629 |
|
|
|
|
99,450 |
|
|
|
103,666 |
|
Less: Accumulated depreciation |
|
|
(76,324 |
) |
|
|
(79,968 |
) |
Property and equipment, net |
|
$ |
23,126 |
|
|
$ |
23,698 |
|
Depreciation expense related to property and equipment for the three months ended September 30, 2018 and 2017 was $2.1 million and $2.5 million, respectively.
Accumulated Other Comprehensive Income
The changes in accumulated other comprehensive income are excluded from earnings and reported as a component of stockholders’ equity. The foreign currency translation adjustment results from those subsidiaries not using the U.S. Dollar as their functional currency since the majority of their economic activities are primarily denominated in their applicable local currency. Accordingly, all assets and
13
liabilities related to these operations are translated to the U.S. Dollar at the current exchange rates at the end of each period. Revenues and expenses are translated at average exchange rates in effect during the period.
The components of accumulated other comprehensive income in the equity section of the balance sheets are as follows (in thousands):
|
|
September 30, 2018 |
|
|
June 30, 2018 |
|
||
Cumulative foreign currency translation adjustment |
|
$ |
842 |
|
|
$ |
1,237 |
|
Defined benefit pension obligation |
|
|
(144 |
) |
|
|
(144 |
) |
Accumulated other comprehensive income |
|
$ |
698 |
|
|
$ |
1,093 |
|
Note 5. Goodwill and Intangible Assets
Goodwill
Activity related to goodwill consisted of the following (in thousands):
|
|
September 30, 2018 |
|
|
June 30, 2018 |
|
||
Balance at the beginning of the period |
|
$ |
57,855 |
|
|
$ |
57,812 |
|
Currency translation |
|
|
(88 |
) |
|
|
43 |
|
Balance at the end of the period |
|
$ |
57,767 |
|
|
$ |
57,855 |
|
In the second quarter of fiscal 2018, the Company performed its annual goodwill impairment test. Based on this analysis, the Company determined that there was no impairment to goodwill. The Company will continue to monitor its recorded goodwill for indicators of impairment.
Intangible Assets
The Company’s carrying amount of acquired intangible assets, net, is as follows (in thousands):
|
|
|
|
|
|
September 30, 2018 |
|
|
June 30, 2018 |
|
||||||||||||||||||
|
|
Useful Lives |
|
|
Gross Carrying Amount |
|
|
Accumulated Amortization |
|
|
Net Amount |
|
|
Gross Carrying Amount |
|
|
Accumulated Amortization |
|
|
Net Amount |
|
|||||||
|
|
(in years) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patent license |
|
|
7 |
|
|
$ |
1,000 |
|
|
$ |
(215 |
) |
|
$ |
785 |
|
|
$ |
1,000 |
|
|
$ |
(179 |
) |
|
$ |
821 |
|
The Company did not identify any triggering events that would indicate potential impairment of its definite-lived intangible and long-lived assets as of September 30, 2018 and June 30, 2018.
Amortization expense related to intangible assets for the three months ended September 30, 2018 and 2017 was each $0.04 million.
The estimated future amortization expense of acquired intangible assets as of September 30, 2018 is as follows (in thousands):
Year Ending June 30, |
|
Amount |
|
|
2019 (remaining 9 months) |
|
$ |
107 |
|
2020 |
|
|
143 |
|
2021 |
|
|
143 |
|
2022 |
|
|
143 |
|
2023 |
|
|
143 |
|
Thereafter |
|
|
106 |
|
|
|
$ |
785 |
|
14
The Company considers all highly liquid investments held at major banks, certificates of deposit and other securities with original maturities of three months or less to be cash equivalents.
The Company classifies all of its investments as available-for-sale at the time of purchase because management intends that these investments are available for current operations and includes these investments on its balance sheet as short-term investments. Investments with original maturities longer than three months include commercial paper, U.S. agency securities, non-U.S. government securities and investment-grade corporate debt securities. Investments classified as available-for-sale are recorded at fair market value with the related unrealized gains and losses included in accumulated other comprehensive income, a component of stockholders’ equity. Realized gains and losses are recorded based on specific identification of each security’s cost basis.
The Company sold all of its investments in fiscal 2018 and as such, no investments were outstanding as of September 30, 2018 and June 30, 2018.
Note 7. Derivative Financial Instruments
The Company manages some of its foreign currency risk through the purchase of foreign currency forward contracts that hedge against the short-term effect of currency fluctuations. These foreign currency forward contracts have a monthly maturity that mitigates the effect of rate fluctuations on certain local currency denominated intercompany balances, cash, and customer receivables. The Company does not use derivative financial instruments for speculative or trading purposes. These forward contracts are not designated as hedging instruments for accounting purposes. Principal hedged currencies include the Euro, Japanese Yen, Swiss Franc, and U.S. Dollar. There were no outstanding foreign currency forward contracts at the end of September 30, 2018 and June 30, 2018.
The following table provides information about gain (loss) associated with the Company’s derivative financial instruments (in thousands):
|
|
Three Months Ended September 30, |
|
|||||
|
|
2018 |
|
|
2017 |
|
||
Foreign currency exchange gain on foreign contracts |
|
$ |
17 |
|
|
$ |
241 |
|
Foreign currency transactions gain (loss) |
|
|
(530 |
) |
|
|
4 |
|
Note 8. Fair Value Measurements
Fair value is an exit price representing the amount that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy contains three levels of inputs that may be used to measure fair value, as follows:
Level 1— Unadjusted quoted prices that are available in active markets for the identical assets or liabilities at the measurement date.
Level 2— Other observable inputs available at the measurement date, other than quoted prices included in Level 1, either directly or indirectly, including:
|
• |
Quoted prices for similar assets or liabilities in active markets; |
|
• |
Quoted prices for identical or similar assets in non-active markets; |
|
• |
Inputs other than quoted prices that are observable for the asset or liability; and |
|
• |
Inputs that are derived principally from or corroborated by other observable market data. |
Level 3— Unobservable inputs that cannot be corroborated by observable market data and require the use of significant management judgment. These values are generally determined using pricing models for which the assumptions utilize management’s estimates of market participant assumptions.
The Company does not carry any investments, and its cash balance was $68.5 million and $83.1 million at September 30, 2018 and June 30, 2018, respectively.
15
Liabilities That Are Measured at Fair Value on a Nonrecurring Basis
The Company’s debt is measured on a non-recurring basis using Level 2 inputs based upon observable inputs of the Company’s underlying stock price and the time value of the conversion option since an observable quoted price of the 3.75% Convertible Notes (as defined below) are not readily available. The Revolving Credit Facility (as defined below) and the Term Loan (as defined below) (collectively the “Credit Facilities”) are valued at market interest rates, which it considers to be a level 2 fair value measurement. The carrying value of these financial instruments approximate its estimated fair value as there have not been significant changes in the Company’s credit quality or capital markets that would suggest changes in interest rates since the Credit Facilities were issued or amended in December 2017.
The following table summarizes the carrying value and estimated fair value of the Credit Facilities and the 3.75% Convertible Notes (in thousands):
|
|
September 30, 2018 |
|
|
June 30, 2018 |
|
||||||||||
|
|
Carrying Value |
|
|
Fair Value |
|
|
Carrying Value |
|
|
Fair Value |
|
||||
3.75% Convertible Notes |
|
$ |
70,197 |
|
|
$ |
90,100 |
|
|
$ |
69,382 |
|
|
$ |
70,742 |
|
Term Loan Facility |
|
|
38,307 |
|
|
|
38,307 |
|
|
|
38,010 |
|
|
|
38,010 |
|
Revolving Credit Facility |
|
|
20,422 |
|
|
|
20,422 |
|
|
|
23,685 |
|
|
|
23,685 |
|
Total |
|
$ |
128,926 |
|
|
$ |
148,829 |
|
|
$ |
131,077 |
|
|
$ |
132,437 |
|
Note 9. Commitments and Contingencies
Litigation
From time to time, the Company is involved in legal proceedings arising in the ordinary course of its business. The Company records a provision for a loss when it believes that it is both probable that a loss has been incurred and the amount can be reasonably estimated. Currently, management believes the Company does not have any probable and estimable losses related to legal proceedings and claims. Although occasional adverse decisions or settlements may occur, management does not believe that an adverse determination with respect to any of these claims would individually or in the aggregate materially and adversely affect the Company’s financial condition or operating results. Litigation is inherently unpredictable and is subject to significant uncertainties, some of which are beyond the Company’s control. Should any of these estimates and assumptions change or prove to have been incorrect, the Company could incur significant charges related to legal matters that could have a material impact on its results of operations, financial position and cash flows.
Software License Indemnity
Under the terms of the Company’s software license agreements with its customers, the Company agrees that in the event the software sold infringes upon any patent, copyright, trademark, or any other proprietary right of a third-party, it will indemnify its customer licensees against any loss, expense, or liability from any damages that may be awarded against them. The Company includes this infringement indemnification in all of its software license agreements and selected managed services arrangements. In the event the customer cannot use the software or service due to infringement and the Company cannot obtain the right to use, replace or modify the license or service in a commercially feasible manner so that it no longer infringes, then the Company may terminate the license and provide the customer a refund of the fees paid by the customer for the infringing license or service. The Company has not recorded any liability associated with this indemnification, as it is not aware of any pending or threatened actions that represent probable losses as of September 30, 2018.
Note 10. Debt
3.50% Convertible Senior Notes due February 2018
In February 2013, the Company issued 3.50% Convertible Senior Notes due 2018 (the “3.50% Convertible Notes”) under an indenture between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee. Holders of the 3.50% Convertible Notes were entitled to convert their notes at any time until the close of the business day immediately preceding the maturity date of February 1, 2018. The 3.50% Convertible Notes were convertible into common stock of the Company at an initial conversion rate equal to 187.6877 shares of common stock per $1,000 principal amount, which is equivalent to a conversion price of approximately $5.33 per share of common stock, subject to adjustment.
16
On January 30, 2018, the Company entered into exchange agreements (the “Exchange Agreements”) wi<